Modes of FGF release in vivo and in vitro

CANCER AND METASTASIS REVIEW

Volumn 9, Issue 3, 1990, Pages 227-238

  D'Amore, Patricia A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

angiogenesis; autocrine; basement membrane; heparin; injury

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEPARIN;

ANGIOGENESIS; BASEMENT MEMBRANE; HISTOCHEMISTRY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMAL; BASEMENT MEMBRANE; CELL MEMBRANE; FIBROBLAST GROWTH FACTORS; HUMAN; IN VITRO; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025043598     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00046362     Document Type: Article

References (57)

1. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor
2. The effect of fibroblast growth factor on PC12 cells
3. Neurite outgrowth induced by an endothelial cell mitogen isolated from retina
4. Endothelial mitogens derived from retina and hypothalamus: Biological and biochemical similarities
5. Heparin binds endothelial cell growth factor, the principal mitogen in the bovine brain
6. Structural characterization and biological functions of fibroblast growth factor
7. The heparin-binding (fibroblast) growth factor family of proteins
8. Angiogenesis: Factors and mechanisms
9. A family of angiogenic peptides
10. Human basic fibroblast growth factor: nucleotide sequence and genomic organization
11. Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization
12. The fibroblast growth factor family: structural and biological properties
13. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted
14. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix
15. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth
16. Basic fibroblast growth factor (bFGF) is an autocrine regulator of microvascular endothelial cell proliferation
17. Fibroblast growth factor release by bovine endothelial cells and human astrocytoma cells in culture is density dependent
18. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis
19. Expression of human basic fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth
20. Basic fibroblast growth factor fused to a signal peptide transforms cells
21. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number of suramin
22. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretion mechanism
23. Cellular shape is determined by extracellular matrix and is responsible for the control of cellular growth and function
24. Characterization of a factor that promotes neurite out-growth: evidence linking activity to a heparan sulfate proteoglycan
25. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells
26. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
27. Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix
28. A heparin-binding angiogenic protein — basic fibroblast growth factor — is stored within basement membrane
29. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle
30. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for longterm stimulation of plasminogen activator production and DNA synthesis
31. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form
32. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life
33. Heparin protects basic and acidic FGF from inactivation
34. Heparan sulfates of cultured cells. II. Acidsoluble and - precipitable species of different cell lines
35. Heparin-lipoprotein lipase interactions
36. Binding of lipoprotein lipase to endothelial cells
37. Heparin-induced diamine oxidase increase in human blood plasma
38. Heparin-induced release of extracellular superoxide dismutase to human blood plasma
39. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells
40. Mast cells and tumor angiogenesis
41. Heparin and growth control of vascular cells
42. The fate of intravenously administered bFGF and the effect of heparin
43. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion
44. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells
45. An activated form of TGF-β is produced by co-cultures of endothelial cells and pericytes
46. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium
47. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells
48. Gastrointestinal cell plasma membrane wounding and resealing in vivo
49. Growth factors are released by mechanically wounded endothelial cells
50. Do ischemic hearts stimulate endothelial cell growth?
51. The development of a quantitative RIA for basic fibroblast growth factor using polyclonal antibodies against the 157 amino acid form of human bFGF. The identification of bFGF in adherent elicited murine peritoneal macrophages
52. Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach of the fibrotic disorders
53. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor